Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by slaveonfoolson Aug 12, 2013 3:18pm

120 Views

Post# 21664419

Bids building, see if we can dent those 11.5s before close

Level 2 Quote

Shares	Bid Price	Ask Price	Shares
53,000	0.110	0.115	204,500
46,000	0.105	0.120	82,000
131,000	0.100	0.125	111,000
101,500	0.095	0.130	80,000
294,000	0.090	0.135	30,000
83,000	0.085	0.140	120,000
180,000	0.080	0.145	26,000
4,000	0.075	0.150	155,000
56,000	0.065	0.155	5,000
40,000	0.055	0.160	11,000